OP0147 Targeted treatment with combination DMARDs produces excellent clinical and radiographic long-term outcomes in early rheumatoid arthritis regardless of initial infliximab. The 5-year follow-up results of the neo-raco trial

Abstract

BackgroundThe treatment of rheumatoid arthritis (RA) should aim at remission. A substantial part of the patients may achieve this target when an initial treatment with a combination of disease modifying...